CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance
DOI 10.1055/s-0033-1341837
Bibliografische Angaben
Nachweis in CareLit
Autor:innenN Müller, S Hillebrand, DM Schulte, K Türk, K Neumann, M Stelmach-Mardas, J Hampe, C Schafmayer, M Brosch, W von Schönfels, M Ahrens, C Gutschow, R Zeuner, JO Schröder, M Blüher, S Schreiber, M Laudes
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Objective: B lymphocyte stimulator (BLyS) was considered as a novel adipokine in mice inducing low-grade inflammation and insulin resistance in obesity. Therefore, our aim was to examine (1) whether BLyS expression in human adipocytes in vivo differs between lean and obese ± insulin resistant subjects, (2) whether BLyS serum concentrations are dysregulated in obesity ± insulin resistance, (3) whether…
Zitieren
Zitierempfehlung
N Müller, S Hillebrand, DM Schulte, K Türk, K Neumann, M Stelmach-Mardas, J Hampe, C Schafmayer, M Brosch, W von Schönfels, M Ahrens, C Gutschow, R Zeuner, JO Schröder, M Blüher, S Schreiber, M Laudes (2013) B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0033-1341837
Mit CareLit weiterarbeiten